Floatz logo

ac676

Relapsed/Refractory B-cell Malignancies

Accutar Biotechnology IncPhase 1
Rating in progress

ac676 in Relapsed/Refractory B-cell Malignancies is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active